biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > A Buyout, Or Something Else?

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton Nov 01, 2022 9:33pm

126 Views

Post# 35065040

RE:RE:RE:A Buyout, Or Something Else?

I agree, beenthere. I don't think this forum should be subjected to anything complicated to read, nor should anybody have to think, let alone overthink, about anything,

I don't think that you have anything to worry about. You neither read nor overthink anything.

It's probably best for some people to just sit and wait for things to happen, or not happen.

jd

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario